Impact of Neurochecks on Sleep in Critically Ill Adults

Status Recruiting

Clinical Trial Summary

Background: Following acute brain injury (ABI), patients are monitored in the intensive care unit (ICU) where providers rely on frequent neurological examinations ("neurochecks") to assess for neurodeterioration. Serial neurochecks are part of guideline recommendations, but there is equipoise between hourly (Q1) and every-other-hour (Q2) evaluation. In the ICU, care-related awakenings occur frequently, but it is unclear if differential neurocheck frequencies result in differential sleep, providing the scientific premise for this proposal. Population: Thirty patients (N=15 per group) who have undergone elective aneurysm coiling will be enrolled. On post-operative day (POD) 0, patients will be screened and approached for informed consent if they do not meet exclusion criteria, e.g., prior intracranial injury, sleep disorders, cognitive impairment, mechanical ventilation. Patients with elective aneurysm coiling are being chosen because they require ICU level of care following their intracranial procedure, but do not have structural brain injury or ongoing sedation needs that might impact sleep measurements. Methods: Usual care: Patients are monitored every 15-30 minutes for up to 6 hours post-procedure, then Q1 or Q2 for up to 24 hours. If these patients remain stable, they are discharged home on post-operative day (POD) 1. Proposed Intervention: Enrolled patients will be randomized to Q1 or Q2 neurochecks following the institutionally required 6 hours of stable neurological and vascular checks. Once randomized, patients will undergo placement of electroencephalogram (EEG) with video, electrooculogram, and chin lead. The video EEG will be in place for at least 8 hours to include the overnight (10PM-6AM) time period. Following completion of the recording, the signals obtained will be reviewed by a blinded polysomnographic sleep technician for sleep characteristics including quantitative assessments of wakefulness, deep (N3) sleep, REM sleep, sleep efficiency, and sleep fragmentation and arousals. On POD1, patients and their nurse will fill out the Richards-Campbell Sleep Questionnaire to rate subjective sleep quality.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05864300
Study type	Interventional
Source	University of California, San Diego
Contact	Jamie N LaBuzetta
Phone	619-543-6222
Email	jlabuzetta@ucsd.edu
Status	Recruiting
Phase	N/A
Start date	August 11, 2023
Completion date	October 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04583163` - Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Recruiting	`NCT03306823` - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1	N/A
Recruiting	`NCT03306836` - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2	N/A
Recruiting	`NCT02345395` - Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms	N/A
Completed	`NCT00962546` - Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage	N/A
Recruiting	`NCT04141020` - Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms	Phase 2
Recruiting	`NCT01460563` - Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia	N/A
Completed	`NCT02507999` - Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients	N/A
Recruiting	`NCT02162654` - Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment	N/A
Completed	`NCT01943591` - DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial	N/A
Recruiting	`NCT03815149` - Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Completed	`NCT03152201` - New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms
Recruiting	`NCT02444832` - Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy	N/A
Active, not recruiting	`NCT05774782` - Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification	N/A
Withdrawn	`NCT01878136` - Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage	Phase 1/Phase 2
Completed	`NCT02455440` - Esmolol Infusion in Patients Undergoing Craniotomy	Phase 3
Withdrawn	`NCT02011321` - Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)	Phase 2
Completed	`NCT00614887` - Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage
Terminated	`NCT02281721` - Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
Completed	`NCT04963933` - A Medical Device to Treat Brain Aneurysms	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.